Diabetes aktuell 2010; 8(3): 124-130
DOI: 10.1055/s-0030-1255420
Schwerpunkt

© Georg Thieme Verlag Stuttgart · New York

Bariatrische Operationen bei Adipositas und Typ-2-Diabetes – Typ-2-Diabetiker profitieren überproportional

Bariatric Surgery of Adipose Patients and Type 2 Diabetics – Super-Proportional Benefits by Type 2 DiabeticsWinfried Keuthage1
  • 1Diabetologische Schwerpunktpraxis, Münster
Further Information

Publication History

Publication Date:
02 June 2010 (online)

Zusammenfassung

Die Zunahme von Adipositas und ihrer Folgeerkrankungen, insbesondere Typ-2-Diabetes, erfordert die Intensivierung aller bekannten präventiven und therapeutischen Maßnahmen. Hierzu zählen bei Adipositas Grad 3 neben den konservativen Programmen gegebenenfalls auch adipositaschirurgische (bariatrische) Operationen. Typ-2-Diabetiker profitieren überproportional, da sich unmittelbar nach insbesondere malabsorptiven Operationsverfahren die Stoffwechsellage dramatisch bessert, und zwar unabhängig von der erst im Laufe von Wochen und Monaten beobachteten Gewichtsabnahme. Langzeitstudien mit bis zu 15 Jahren Follow-up belegen den nachhaltigen positiven Effekt bariatrischer Operationen auf Gewichtsverlust, adipositasassoziierte Erkrankungen und Mortalität. Die Arbeitsgruppe Adipositas des BDEM (Bundesverband Deutscher Ernährungsmediziner e. V.) hat einen Behandlungspfad zur Therapie von Personen mit massiver Adipositas entwickelt.

Increasing adiposity and its subsequent diseases, especially Type 2 diabetes, makes it necessary to intensify all the well-known preventive and therapeutic measures. These include, in case of grade 3 adiposity, not only the conservative programmes but also whenever necessary bariatric surgery (adipose patient surgery). This will super-proportionally benefit Type 2 diabetics, since there is an immediate dramatic improvement in the metabolic condition of the patients especially subsequent to malabsorption surgery, independent of the weight loss. The persistently positive effect of bariatric surgery has been established with regard to weight loss, adiposity-associated diseases and mortality, by means of long-term studies with a follow-up of up to 15 years. A guideline for the treatment of highly adipose patients has been compiled by the Federal German Association of Physicians Engaged in Nutritional Medicine.

Literatur

  • 1 Busetto L et al.. Weight loss and postoperative complications in morbidly obese patients with binge eating disorder treated by laparoscopic adjustable gastric banding.  Obes Surg. 2005;  15 195-201
  • 2 International Federation for the Surgery of Obesity. . Statement on patient selection for bariatric surgery.  Obes Surg. 1997;  7 41
  • 3 Schilling-Massmann B et al.. Adipositastherapie bei massiv adipösen Patienten.  Ernährungs Umschau. 2009;  4 246-247
  • 4 Mechanick JI et al.. AACE/TOS/ASMBS Bariatric Surgery Guidelines.  Endocr Pract. 2008;  14 (S 01) 1-83
  • 5 Fried M et al.. Inter-disciplinary European guidelines on surgery of severe obesity.  Int J of Obes. 2007;  31 1-9
  • 6 Weiner R et al.. Adipositaschirurgie.. München: Urban & Fischer Verlag; 2010
  • 7 Almogy G et al.. Longitudinal gastrectomy as a treatment for the high-risk super-obese patient.  Obes Surg. 2004;  14 492-497
  • 8 Lancaster RT et al.. Bands and bypasses: 30-day morbidity and mortality of bariatric surgical procedures as assessed by prospective, multi-center, risk-adjusted ACS-NSQIP data.  Surg Endosc. 2008;  22 2554-2563
  • 9 Jan J et al.. Comparative study between laparoscopic adjustable gastric banding and laparoscopic gastric bypass: single-institution, 5-year experience in bariatric surgery.  Surg Obes Relat Dis. 2007;  3 42-50
  • 10 Buchwald H et al.. Trends in mortality in bariatric surgery: a systematic review and meta-analysis.  Surgery. 2007;  142 621-632
  • 11 Buchwald H et al.. Bariatric surgery: a systematic review and metaanalysis.  JAMA. 2004;  292 1724-1737
  • 12 Sjoström L et al.. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study.  Obes Res. 1999;  7 477-484
  • 13 Sjoström L et al.. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.  N Engl J Med. 2004;  351 2683-2693
  • 14 Sjoström L et al.. Effects of bariatric surgery on mortality in Swedish obese subjects.  N Engl J Med. 2007;  357 741-752
  • 15 Dixon JB et al.. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial.  JAMA. 2008;  299 316-323
  • 16 Aggarwal S et al.. Laparoscopic sleeve gastrectomy for morbid obesity: a review.  Surg Obes Relat Dis. 2007;  3 189-194
  • 17 Pories WJ et al.. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus.  Ann Surg. 1995;  222 339-350
  • 18 Herbst CA et al.. Gastric bariatric operation in insulin-treated adults.  Surgery. 1984;  95 209-214
  • 19 Long SD et al.. Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study.  Diabetes Care. 1994;  17 372-375
  • 20 Narbro K et al.. Economic consequenses of sick-leave and eartly retirement in obese Swedish women.  Int J Obes. 1996;  20 895-903
  • 21 Herpertz S et al.. Does obesity surgery improve psychosocial functioning? A systematic review.  Int J Obes Relat Metab Disord. 2003;  27 1300-1314
  • 22 Herpertz S et al.. Do psychosocial variables predict weight loss or mental health after obesity surgery? A systematic review.  Obes Res. 2004;  12 1554-1569
  • 23 de Zwaan M et al.. Essverhalten vor und nach adipositaschirurgischer Behandlung.  Aktuelle Ernährungsmedizin. 2009;  34 83-87
  • 24 MacDonald KG et al.. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus.  J Gastrointest Surg. 1997;  1 213-220
  • 25 Harper J et al.. What happens to patients who do not follow-up after bariatric surgery?.  Am Surg. 2007;  73 181-184
  • 26 Orth WS et al.. Support group meeting attendance is associated with better weight loss.  Obes Surg. 2008;  18 391-394
  • 27 Ridley N et al.. Expert panel on weight loss surgery: Executive report.  Obes Res. 2005;  13 206-226
  • 28 Gasteyger C et al.. Nutritional deficiencies after Roux-en-Y gastric bypass for morbid obesity often cannot be prevented by standard multivitamin supplementation.  Am J Clin Nutr. 2008;  87 1128-1133
  • 29 Coupaye M et al.. Nutritional consequences of adjustable gastric banding and gastric bypass: a 1-year prospective study.  Obes Surg. 2009;  19 56-65
  • 30 Schilling-Massmann B, Keuthage W.. Extrabudgetäre Kostenerstattung für ernährungsmedizinische Vor- und Nachsorge bei hochgradiger Adipositas.  Ernährungsumschau. 2010;  57
  • 31 Christou NV et al.. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients.  Ann Surg. 2004;  240 416-423
  • 32 Rand CS et al.. Surgery for obesity and marriage quality.  JAMA. 1982;  247 1419-1422

Korrespondenz

Dr. med. Winfried Keuthage

Diabetologische Schwerpunkt-praxis Schwerpunktpraxis Ernährungsmedizin

Düesbergweg 128

48153 Münster

Email: dr@keuthage.de